USD 0.13
(2.84%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | -133.27 Thousand USD | -72.37% |
2020 | -714.17 Thousand USD | 511.46% |
2019 | -1.24 Million USD | -191.12% |
2018 | -269.04 Thousand USD | -3750.47% |
2017 | 47.51 Thousand USD | 104.99% |
2016 | -147.62 Thousand USD | -572.65% |
2015 | -21.94 Thousand USD | -71.28% |
2014 | -12.81 Thousand USD | 66.46% |
2013 | -38.2 Thousand USD | -106663.18% |
2012 | -35.78 USD | 99.95% |
2011 | -66.73 Thousand USD | 14.4% |
2010 | -77.96 Thousand USD | 10.7% |
2009 | -87.3 Thousand USD | 35.9% |
2008 | -136.18 Thousand USD | -304.54% |
2007 | -33.66 Thousand USD | -51.95% |
2006 | -22.15 Thousand USD | 14.92% |
2005 | -26.04 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2022 Q1 | -36.43 Thousand USD | -107.16% |
2022 Q2 | 482.5 Thousand USD | 1424.48% |
2022 Q3 | 271.22 Thousand USD | -43.79% |
2021 Q2 | 426.7 Thousand USD | 670.67% |
2021 Q4 | 508.95 Thousand USD | 605.96% |
2021 Q1 | 55.36 Thousand USD | 117.35% |
2021 FY | - USD | -72.37% |
2021 Q3 | -100.59 Thousand USD | -123.57% |
2020 Q2 | -80.89 Thousand USD | 27.88% |
2020 Q3 | -210.04 Thousand USD | -159.66% |
2020 Q1 | -112.16 Thousand USD | 38.2% |
2020 Q4 | -319.12 Thousand USD | -51.93% |
2020 FY | - USD | 511.46% |
2019 FY | - USD | -191.12% |
2019 Q4 | -181.49 Thousand USD | 76.45% |
2019 Q2 | -13.21 Thousand USD | 99.95% |
2019 Q3 | -770.82 Thousand USD | -5733.43% |
2019 Q1 | -27.3 Million USD | -25117.98% |
2018 Q2 | -59.34 Thousand USD | 40.96% |
2018 FY | - USD | -3750.47% |
2018 Q4 | -108.28 Thousand USD | -5308.32% |
2018 Q3 | 2079.00 USD | 103.5% |
2018 Q1 | -100.5 Thousand USD | -361.54% |
2017 Q2 | -24.32 Thousand USD | 18.12% |
2017 Q4 | 38.42 Thousand USD | 242.21% |
2017 Q3 | -27.02 Thousand USD | -11.08% |
2017 Q1 | -29.71 Thousand USD | -29.15% |
2017 FY | - USD | 104.99% |
2016 Q2 | -22.6 Thousand USD | 31.09% |
2016 Q4 | -23 Thousand USD | -21.3% |
2016 Q3 | -18.96 Thousand USD | 16.1% |
2016 FY | - USD | -572.65% |
2016 Q1 | -32.8 Thousand USD | -36.03% |
2015 Q1 | -32.97 Thousand USD | -38.39% |
2015 Q3 | -27.83 Thousand USD | 13.63% |
2015 Q4 | -24.11 Thousand USD | 13.35% |
2015 FY | - USD | -71.28% |
2015 Q2 | -32.22 Thousand USD | 2.26% |
2014 Q1 | -21.08 Thousand USD | 28.49% |
2014 Q2 | -25.73 Thousand USD | -22.03% |
2014 FY | - USD | 66.46% |
2014 Q3 | -20.71 Thousand USD | 19.49% |
2014 Q4 | -23.82 Thousand USD | -15.0% |
2013 Q2 | -24.38 Thousand USD | 6.28% |
2013 Q1 | -26.01 Thousand USD | -10.11% |
2013 Q4 | -29.48 Thousand USD | -8.01% |
2013 FY | - USD | -106663.18% |
2013 Q3 | -27.3 Thousand USD | -11.98% |
2012 FY | - USD | 99.95% |
2012 Q3 | -26.56 Thousand USD | -31.6% |
2012 Q2 | -20.18 Thousand USD | -5.44% |
2012 Q4 | -23.62 Thousand USD | 11.04% |
2012 Q1 | -19.14 Thousand USD | -110.96% |
2011 Q3 | -19.04 Thousand USD | -0.11% |
2011 FY | - USD | 14.4% |
2011 Q4 | -9073.00 USD | 52.36% |
2011 Q2 | -19.02 Thousand USD | 2.87% |
2011 Q1 | -19.58 Thousand USD | 3.41% |
2010 FY | - USD | 10.7% |
2010 Q1 | -20.18 Thousand USD | -75.3% |
2010 Q2 | -17.3 Thousand USD | 14.25% |
2010 Q3 | -20.19 Thousand USD | -16.71% |
2010 Q4 | -20.27 Thousand USD | -0.41% |
2009 Q3 | -23.61 Thousand USD | -10.04% |
2009 Q4 | -11.51 Thousand USD | 51.24% |
2009 Q2 | -21.45 Thousand USD | 30.16% |
2009 Q1 | -30.72 Thousand USD | -368.72% |
2009 FY | - USD | 35.9% |
2008 Q1 | -20.66 Thousand USD | -13.15% |
2008 Q2 | -18.06 Thousand USD | 12.56% |
2008 Q4 | 11.43 Thousand USD | 119.41% |
2008 Q3 | -58.89 Thousand USD | -226.02% |
2008 FY | - USD | -304.54% |
2007 FY | - USD | -51.95% |
2007 Q1 | -2059.00 USD | 58.32% |
2007 Q3 | -8294.00 USD | -64.14% |
2007 Q2 | -5053.00 USD | -145.41% |
2007 Q4 | -18.25 Thousand USD | -120.15% |
2006 Q2 | -3536.00 USD | 22.46% |
2006 Q4 | -4940.00 USD | 45.83% |
2006 FY | - USD | 14.92% |
2006 Q3 | -9120.00 USD | -157.92% |
2006 Q1 | -4560.00 USD | 0.0% |
2005 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
The Amacore Group, Inc. | -10.98 Million USD | 100.0% |
Arem Pacific Corporation | 36.71 Thousand USD | 100.0% |
Assisted 4 Living, Inc. | -112.91 Thousand USD | 100.0% |
BioCorRx Inc. | -2.68 Million USD | 100.0% |
Bionik Laboratories Corp. | -4.77 Million USD | 100.0% |
Banyan Corp. | 583.94 Thousand USD | 100.0% |
Clearday, Inc. | -7.53 Million USD | 100.0% |
Dental Patient Care America, Inc. | 12.87 Thousand USD | 100.0% |
Quantum Medical Transport, Inc. | - USD | NaN% |
Empower Clinics Inc. | -1.08 Million USD | 100.0% |
First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 100.0% |
Selectis Health, Inc. | -7.29 Million USD | 100.0% |
Ethema Health Corporation | 2.07 Million USD | 100.0% |
HealthLynked Corp. | -2.75 Million USD | 100.0% |
Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 100.0% |
JRSIS Health Care Corporation | 28.84 Thousand USD | 100.0% |
Comjoyful International Company | 167.89 Thousand USD | 100.0% |
Medical Facilities Corporation | 77.94 Million USD | 100.0% |
MedSmart Group Inc. | 47.8 Thousand USD | 100.0% |
North America Frac Sand, Inc. | -623.33 Thousand USD | 100.0% |
Nova Leap Health Corp. | 994.46 Thousand USD | 100.0% |
Nexteligent Holdings, Inc. | -201.73 Thousand USD | 100.0% |
PAO Group, Inc. | 292.96 Thousand USD | 100.0% |
Primemd Inc. | 3.42 Million USD | 100.0% |
Raffles Medical Group Ltd | 100.7 Million USD | 100.0% |
Ryman Healthcare Limited | -54.51 Million USD | 100.0% |
Stem Cell Authority, Ltd. | -4233.00 USD | 100.0% |
SETO Holdings, Inc. | - USD | NaN% |
Optima Medical Innovations Corp. | -2.89 Million USD | 100.0% |
Mycotopia Therapies, Inc. | -555.5 Thousand USD | 100.0% |
U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 100.0% |
Veltex Corporation | -938.45 Thousand USD | 100.0% |
World Financial Holding Group | -28.43 Thousand USD | 100.0% |
Xcelerate Inc. | -2.53 Million USD | 100.0% |